Welcome to our new Journal dedicated to the thriving field of Molecular Medicine. EMBO Molecular Medicine publishes original research at the interface between molecular biology and clinical research that is highly relevant to understand, prevent and treat human diseases.
Launching a journal is an exciting challenge. All of us at the European Molecular Biology Organization (EMBO) and our publisher Wiley have high ambitions for this new venture. We are thus particularly proud to present our first issue that embodies much of what we want our Journal to be. It brings you high quality, stimulating science; illustrating our broad scope, this month's research articles report on a mouse model for a behavioural syndrome that provides new insights into the molecular basis of the human phenotypes, an analysis of the remarkable mode of action of a novel antibiotic and exciting data that open up potential innovative treatments of cancer and inherited respiratory deficiencies. Our attractive front‐half section will cover a variety of topics central to the Molecular Medicine community and will alert you to news, developments and trends in the area. In this issue, you can find out our views on the Journal and the field by reading our ‘Editorials’, we feature a ‘Closeup’ article highlighting one of our papers, an ‘In Focus’, a short topical piece, discussing the threats posed by haemorrhagic fever viruses and a ‘Review’ calling your attention to the so far neglected role of dendritic cells in tuberculosis and proposing new targets to fight this disease.
»It brings you high quality, stimulating science.«
We saved some surprises for the next issues too! In addition to the article types just mentioned, we will also introduce a novel article type named ‘Bridge the Gap’ as it aims to contribute to bridging the bench–bedside/bedside–bench gaps. This will be one of the many features of the Journal that will relay thoughts, ideas, questions and solutions to support the molecular medicine community in its efforts towards improving human medical care.
We are determined to make this Journal a quality and friendly forum for our authors and readers. Authors will receive a fair, expert and quick editorial process for all their articles. Our prestigious panel of Senior Editors and Advisory Editorial Board as well as myself are fully committed to offer you the highest editorial standards. Articles will be available online within 48 h of acceptance to maximize their exposure. We will feature highlights and closeups on selected articles. Furthermore, throughout the years 2009 and 2010 all our content will be freely available (online and in print) to anyone whose Institution opts‐in for complimentary access.
To increase the visibility and impact of our papers to the broadest possible audience, articles will display features that will include ‘The paper explained’ section, or a Glossary to clarify the research or particular terms to others not familiar with the field and its jargon. Readers looking for more information can follow relevant web‐links listed at the end of the article. Please visit our dynamic website with many interesting features that will provide a reliable, informative and exciting scientific portal to the Molecular Medicine community.
»Authors will receive a fair, expert and quick editorial process for all their articles.«
We want to maintain an interactive relationship with all of you. We are eager to know your opinion on the Journal, the research it publishes and, the paths Molecular Medicine is taking, and to listen to your suggestions.. . . As the other EMBO publications and activities, this Journal will update and renovate itself to keep up with this fast growing multi‐disciplinary field, meet your expectations and provide the best service to your community. Enjoy our Journal and all it has to offer you!
»We want to maintain an interactive relationship with all of you.«
↵† Sandra Caldeira is the Editor of the Journal and is at EMBO.
- Copyright © 2009 EMBO Molecular Medicine